Ranibizumab
暂无分享,去创建一个
[1] R. Klein,et al. Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy. , 2013, Ophthalmology.
[2] T. Lai,et al. Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema , 2013, Clinical interventions in aging.
[3] J. Frampton. Ranibizumab: A Review of Its Use in the Treatment of Neovascular Age-Related Macular Degeneration , 2013, Drugs & Aging.
[4] F. Boscia. Current Approaches to the Management of Diabetic Retinopathy and Diabetic Macular Oedema , 2010, Drugs.
[5] A. Lauer,et al. Emerging Therapies for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema , 2012, BioDrugs.
[6] M. Parodi,et al. Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema , 2011, Clinical ophthalmology.
[7] L. Aiello,et al. RANDOMIZED TRIAL EVALUATING SHORT-TERM EFFECTS OF INTRAVITREAL RANIBIZUMAB OR TRIAMCINOLONE ACETONIDE ON MACULAR EDEMA AFTER FOCAL/GRID LASER FOR DIABETIC MACULAR EDEMA IN EYES ALSO RECEIVING PANRETINAL PHOTOCOAGULATION , 2011, Retina.
[8] Jennifer K. Sun,et al. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. , 2011, Ophthalmology.
[9] Francesco Bandello,et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. , 2011, Ophthalmology.
[10] Elham Hatef,et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. , 2010, Ophthalmology.
[11] Simon P. Harding,et al. Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study) , 2010, Diabetes Care.
[12] Napoleone Ferrara,et al. Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy , 2010, Nature Medicine.
[13] M. Laouri,et al. Burden of illness of diabetic macular edema: literature review , 2010, Current medical research and opinion.
[14] Lloyd Paul Aiello,et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema , 2010, Ophthalmology.
[15] M. Blumenkranz. Optimal current and future treatments for diabetic macular oedema , 2010, Eye.
[16] D. Browning. Diabetic Macular Edema , 2010 .
[17] Jennifer I. Lim,et al. Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study. , 2009, Ophthalmology.
[18] G. Querques,et al. SHORT-TERM FLUCTUATION OF DIABETIC MACULAR EDEMA AFTER INTRAVITREAL RANIBIZUMAB INJECTION , 2009, Retina.
[19] Ronald Klein,et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. , 2009, Ophthalmology.
[20] C. Regillo,et al. INCIDENCE OF ENDOPHTHALMITIS RELATED TO INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB , 2008, Retina.
[21] M. Fowler. Microvascular and Macrovascular Complications of Diabetes , 2008, Clinical Diabetes.
[22] Valerie Quarmby,et al. Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo. , 2007, Experimental eye research.
[23] A. Gorst-rasmussen,et al. The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema , 2007, British Journal of Ophthalmology.
[24] P. Campochiaro,et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. , 2006, American journal of ophthalmology.
[25] L. Damico,et al. DEVELOPMENT OF RANIBIZUMAB, AN ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIGEN BINDING FRAGMENT, AS THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2006, Retina.
[26] J. Duker,et al. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. , 2006, Ophthalmology.
[27] F L Ferris,et al. Macular edema. A complication of diabetic retinopathy. , 1984, Survey of ophthalmology.